HomeCompareIARGF vs MRK

IARGF vs MRK: Dividend Comparison 2026

IARGF yields 0.84% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IARGF wins by $2.53M in total portfolio value· pulled ahead in Year 5
10 years
IARGF
IARGF
● Live price
0.84%
Share price
$18.55
Annual div
$0.16
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.58M
Annual income
$2,101,929.60
Full IARGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IARGF vs MRK

📍 IARGF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIARGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IARGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IARGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IARGF
Annual income on $10K today (after 15% tax)
$71.16/yr
After 10yr DRIP, annual income (after tax)
$1,786,640.16/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, IARGF beats the other by $1,778,311.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IARGF + MRK for your $10,000?

IARGF: 50%MRK: 50%
100% MRK50/50100% IARGF
Portfolio after 10yr
$1.32M
Annual income
$1,055,863.87/yr
Blended yield
79.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IARGF
No analyst data
Altman Z
1.9
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IARGF buys
0
MRK buys
0
No recent congressional trades found for IARGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIARGFMRK
Forward yield0.84%2.76%
Annual dividend / share$0.16$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$2.58M$56.8K
Annual income after 10y$2,101,929.60$9,798.13
Total dividends collected$2.52M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IARGF vs MRK ($10,000, DRIP)

YearIARGF PortfolioIARGF Income/yrMRK PortfolioMRK Income/yrGap
1$10,867$167.44$11,206$366.19$339.00MRK
2$11,968$340.12$12,650$502.35$682.00MRK
3$13,506$700.13$14,407$694.19$901.00MRK
4$15,928$1,476.83$16,585$967.82$657.00MRK
5← crossover$20,299$3,255.49$19,342$1,363.89+$957.00IARGF
6$29,474$7,754.64$22,913$1,947.19+$6.6KIARGF
7$52,584$21,046.57$27,662$2,823.89+$24.9KIARGF
8$126,449$70,183.82$34,159$4,173.35+$92.3KIARGF
9$450,759$315,458.83$43,337$6,308.80+$407.4KIARGF
10$2,584,242$2,101,929.60$56,776$9,798.13+$2.53MIARGF

IARGF vs MRK: Complete Analysis 2026

IARGFStock

IAR Systems Group AB (publ) provides software tools and services for embedded systems development in Sweden. The company offers IAR Embedded Workbench, a development toolchain for embedded software and arm technology. It also provides RISC-V, a specialist product for embedded development; renesas, a development tool for microcontrollers; NXP, a developing application for microcontrollers, as well as offers nuvoton technology, a smart home and cloud security integrated circuit. In addition, the company provides texas instruments such as wireless microcontrollers, and microprocessors; microelectronics and microchips. The company serves automotive, industrial automation, internet of things, medical, and consumer electronics industries. IAR Systems Group AB (publ) was founded in 1983 and is headquartered in Uppsala, Sweden.

Full IARGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IARGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IARGF vs SCHDIARGF vs JEPIIARGF vs OIARGF vs KOIARGF vs MAINIARGF vs JNJIARGF vs ABBVIARGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.